ANAGREDEX anagrelide (as hydrochloride) 0.5 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

anagredex anagrelide (as hydrochloride) 0.5 mg capsule blister pack

micro labs pty ltd - anagrelide hydrochloride, quantity: 0.57 mg (equivalent: anagrelide, qty 0.5 mg) - capsule, hard - excipient ingredients: crospovidone; lactose; lactose monohydrate; povidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; gelatin; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - anagredex capsules are indicated for the treatment of essential thrombocythaemia.

ANAGREDEX anagrelide (as hydrochloride) 0.5 mg capsule bottle Australia - English - Department of Health (Therapeutic Goods Administration)

anagredex anagrelide (as hydrochloride) 0.5 mg capsule bottle

micro labs pty ltd - anagrelide hydrochloride, quantity: 0.57 mg (equivalent: anagrelide, qty 0.5 mg) - capsule, hard - excipient ingredients: crospovidone; microcrystalline cellulose; lactose; lactose monohydrate; povidone; magnesium stearate; titanium dioxide; gelatin; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - anagredex capsules are indicated for the treatment of essential thrombocythaemia.

ANAGRIDE anagrelide (as hydrochloride) 0.5 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

anagride anagrelide (as hydrochloride) 0.5 mg capsule blister pack

micro labs pty ltd - anagrelide hydrochloride, quantity: 0.57 mg (equivalent: anagrelide, qty 0.5 mg) - capsule, hard - excipient ingredients: lactose monohydrate; lactose; povidone; crospovidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; gelatin; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - anagride capsules are indicated for the treatment of essential thrombocythaemia.

ANAGRIDE anagrelide (as hydrochloride) 0.5 mg capsule bottle Australia - English - Department of Health (Therapeutic Goods Administration)

anagride anagrelide (as hydrochloride) 0.5 mg capsule bottle

micro labs pty ltd - anagrelide hydrochloride, quantity: 0.57 mg (equivalent: anagrelide, qty 0.5 mg) - capsule, hard - excipient ingredients: lactose; magnesium stearate; povidone; crospovidone; lactose monohydrate; microcrystalline cellulose; titanium dioxide; gelatin; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - anagride capsules are indicated for the treatment of essential thrombocythaemia.

AGRYLIN Capsules 0.5mg (アグリリンカプセル0.5mg) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

agrylin capsules 0.5mg (アグリリンカプセル0.5mg)

takeda pharmaceutical company limited. - anagrelide hydrochloride hydrate - white hard capsule, major axis: approx. 14.3 mm, minor axis: approx. 5.32 mm

Agrylin Capsules 0.5mg Namibia - English - Namibia Medicines Regulatory Council

agrylin capsules 0.5mg

shire pharmaceuticals south africa (pty) ltd - anagrelide hcl monohydrate - capsules - each capsule contains anagrelide hydrochloride monohydrate 0,5mg